Advertisement

GI Chair Lopa Mishra to leave MD Anderson Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

LOPA MISHRA has decided to leave MD Anderson Cancer Center, effective Aug. 31.

Mishra joined MD Anderson in December 2009 as professor and chair of Gastroenterology, Hepatology and Nutrition. In 2010, she was named holder of the Del & Dennis McCarthy Distinguished Professorship. Mishra also serves as associate director of the Texas Digestive Diseases Center.

During Mishra’s tenure, the department grew from one clinical program to eight programs in GI cancers.

In 2013, Gastrointestinal Cancer Program was awarded an “exceptional-outstanding” score by NCI as part of MD Anderson’s cancer center support grant. Mishra also initiated the first MD Anderson Global Academic Program with sub-Saharan Africa, including Ethiopia, Kenya and South Africa.

Mishra’s research has focused on targeting liver and GI cancers using the TGF-beta signaling pathway and stem-like tumor initiating cells. Using mouse and human genetic studies, her team identified a group of liver and GI stem cell proteins crucial for TGF-beta signaling and modulation of human GI cancers and Beckwith-Wiedemann Syndrome. Studies have yielded insights into the origins of hepatocellular carcinoma, 40 percent of which are clonal and could arise from STICs. Her research has led to more than 80 original articles in peer-reviewed journals.

Mishra has received many honors including: American Gastroenterological Association Award for Top Women in Gastroenterology (2008), Funderburg Scholar in Gastric Cancer (2003-05), Betty and Harry Myerberg Award for Excellence in Research in Liver Development (1998), Elisabeth and John Cox Award for Innovative Clinical Therapy of Esophageal Cancer (1996), USV Industry New Investigator Award (1995) and the Stuart Mill Prize in Tropical Medicine (1981).

Marta Davila will serve as chair ad interim.

Advertisement

Davila earned her medical degree from Harvard and completed her residency in Internal Medicine and Fellowship in Gastroenterology at the University of California, San Francisco. Her first faculty appointment was as assistant professor at Stanford Medical School.

She joined MD Anderson in 2004 as associate professor, and was promoted to professor in 2010. In 2014 Davila was named medical director of endoscopy. From 2007 to 2009, she served as interim deputy chair.

Advertisement
Advertisement
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.
Advertisement
Advertisement